Rifabutin Concentrated Solution for Infusion(BioVersys)

利福布汀注射用浓溶液（BioVersys）

Report date: 2026/04/08 15:33:18
NME

Base Information

Drug NameRifabutin Concentrated Solution for Infusion(BioVersys)
Drug Alias Namerifabutine利福布丁rifabutina利福有丁rifabutinum +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial DNA-directed RNA polymerase inhibitors
TargetsBacterial DNA-directed RNA polymerase
Therapy Area/IndicationsAcinetobacter Baumannii Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBioVersys AG
China Registration ClassN/A

Develop Information

Active CompaniesBioVersys AG
Inactive CompaniesN/A
Active IndicationsAcinetobacter Baumannii Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG